Venus Pharma GmbH offers EU CTD Dossiers for Europe & other regulated markets. Further, we have a varied range.
More
With the assistance of our GLP accredited Research unit, Venus Medicine Research Center, we are developing.
More
In strict adherence to EU GMP rules & with complete confidentiality, Venus Pharma GmbH offers commercial.
More
We offer batch release facility of pharmaceutical formulations along with
testing in our laboratories.
Venus Pharma GmbH is equipped with the following also.Dedicated packaging area for Cephalosporins, Oncology.
More
Warehousing is an area of expertise for VPG. The company owns & operates a 3200 pallet storage capicity warehouse.
More
Hub for multiple business models- Tech Transfer, In-Licensing, Out-Licensing, Product development, Site Variation, Packaging, Warehousing and Batch Release.
Successful completion of 10 years of being into EU market. Its all about the intellectual capital that is our primary business driver.
Meropenem became our prime product in EU with supply of more than 4.5 Million vials. Established Gemcitabine in UK with NHS Tenders’ supply.
Launched our Anti-cancer & Anti-biotics in the markets of Germany & UK.
Established footprints in the prime markets of Middle East with focus on Syria.
Acquisition of a Manufacturing Plant at Werne, Germany and transforming it to “VENUS PHARMA GmbH”
